{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T20:35:36Z","timestamp":1770237336139,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.atherosclerosis.2017.09.034","type":"journal-article","created":{"date-parts":[[2017,9,30]],"date-time":"2017-09-30T00:46:49Z","timestamp":1506732409000},"page":"103-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["4-phenylbutyrate and valproate treatment attenuates the progression of atherosclerosis and stabilizes existing plaques"],"prefix":"10.1016","volume":"266","author":[{"given":"Aric","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tayler L.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vi T.","family":"Dang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cameron S.","family":"McAlpine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoff H.","family":"Werstuck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib1","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/CIR.0000000000000157","article-title":"Executive summary: heart disease and stroke statistics\u20142015 update","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib2","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1161\/hc4601.099487","article-title":"Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization","volume":"104","author":"Yusuf","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib3","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","article-title":"Macrophages in the pathogenesis of atherosclerosis","volume":"145","author":"Moore","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib6","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1161\/ATVBAHA.111.224881","article-title":"Mechanisms of ER stress-induced apoptosis in atherosclerosis","volume":"31","author":"Scull","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib7","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.yjmcc.2009.10.026","article-title":"ER stress in cardiovascular disease","volume":"48","author":"Minamino","year":"2010","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib8","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1089\/ars.2009.2569","article-title":"Evidence supporting a role for endoplasmic reticulum stress in the development of atherosclerosis in a hyperglycaemic mouse model","volume":"11","author":"Khan","year":"2009","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrm2199","article-title":"Signal integration in the endoplasmic reticulum unfolded protein response","volume":"8","author":"Ron","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib10","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00507.2009","article-title":"Hexosamine biosynthesis pathway flux promotes endoplasmic reticulum stress, lipid accumulation, and inflammatory gene expression in hepatic cells","volume":"298","author":"Sage","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib11","doi-asserted-by":"crossref","first-page":"45257","DOI":"10.1074\/jbc.M408235200","article-title":"Proteolytic activation of sterol regulatory element-binding protein induced by cellular stress through depletion of Insig-1","volume":"279","author":"Lee","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib12","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/ncb0311-184","article-title":"Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress","volume":"13","author":"Tabas","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev-med-043010-144749","article-title":"Role of endoplasmic reticulum stress in metabolic disease and other disorders","volume":"63","author":"Ozcan","year":"2012","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib14","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nm.2067","article-title":"Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis","volume":"15","author":"Erbay","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib15","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1194\/jlr.M051094","article-title":"Protein kinase R-like endoplasmic reticulum kinase and glycogen synthase kinase-3\u03b1\/\u03b2 regulate foam cell formation","volume":"55","author":"McAlpine","year":"2014","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib16","doi-asserted-by":"crossref","first-page":"44701","DOI":"10.1074\/jbc.M206047200","article-title":"Central role of glycogen synthase kinase-3beta in endoplasmic reticulum stress-induced caspase-3 activation","volume":"277","author":"Song","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib17","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1016\/j.ajpath.2014.07.028","article-title":"Glycogen synthase kinase 3\u03b1 deficiency attenuates atherosclerosis and hepatic steatosis in high fat diet\u2013fed low density lipoprotein receptor\u2013deficient mice","volume":"184","author":"Banko","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib18","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrd1415","article-title":"GSK3 inhibitors: development and therapeutic potential","volume":"3","author":"Cohen","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib19","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2353\/ajpath.2009.080385","article-title":"Valproate attenuates accelerated atherosclerosis in hyperglycemic ApoE-deficient mice: evidence in support of a role for endoplasmic reticulum stress and glycogen synthase kinase-3 in lesion development and hepatic steatosis","volume":"174","author":"Bowes","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib20","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1161\/ATVBAHA.115.305438","article-title":"Deletion of myeloid GSK3\u03b1 attenuates atherosclerosis and promotes an M2 macrophage phenotype","volume":"35","author":"McAlpine","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib21","doi-asserted-by":"crossref","first-page":"35037","DOI":"10.1038\/srep35037","article-title":"Comprehensive plasma metabolomic analyses of atherosclerotic progression reveal alterations in glycerophospholipid and sphingolipid metabolism in apolipoprotein E-deficient mice","volume":"6","author":"Dang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib22","doi-asserted-by":"crossref","first-page":"12610","DOI":"10.1073\/pnas.94.23.12610","article-title":"A\u00a0targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism","volume":"94","author":"Rigotti","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib23","first-page":"50933","article-title":"Quantitative analysis and characterization of atherosclerotic lesions in the murine aortic sinus","author":"Venegas-Pino","year":"2013","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib24","doi-asserted-by":"crossref","first-page":"30427","DOI":"10.1074\/jbc.273.46.30427","article-title":"Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice","volume":"273","author":"Towler","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib25","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1126\/science.1128294","article-title":"Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes","volume":"313","author":"\u00d6zcan","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.atherosclerosis.2012.12.026","article-title":"Rapid regression of atherosclerosis with MTP inhibitor treatment","volume":"227","author":"Hewing","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib27","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1172\/JCI57275","article-title":"Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis","volume":"121","author":"Rayner","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib28","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/ATVBAHA.111.237941","article-title":"Endoplasmic reticulum stress and glycogen synthase Kinase-3\u03b2 activation in apolipoprotein E-deficient mouse models of accelerated atherosclerosis","volume":"32","author":"McAlpine","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib29","doi-asserted-by":"crossref","first-page":"R622","DOI":"10.1016\/j.cub.2012.07.004","article-title":"Unfolded protein response","volume":"22","author":"Cao","year":"2012","journal-title":"Curr. Biol."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib30","first-page":"1","article-title":"Glucosamine-induced ER stress accelerates atherogenesis: a potential link between diabetes and cardiovascular disease","volume":"9","author":"Dang","year":"2015","journal-title":"J.\u00a0Mol. Genet. Med."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib31","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1016\/j.bmcl.2004.09.013","article-title":"Examining the correlations between GSK-3 inhibitory properties and anti-convulsant efficacy of valproate and valproate-related compounds","volume":"14","author":"Werstuck","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib32","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1046\/j.1471-4159.2000.0721327.x","article-title":"The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3","volume":"72","author":"Chen","year":"2008","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib33","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0028-3908(02)00215-0","article-title":"Regulation of Akt and glycogen synthase kinase-3\u03b2 phosphorylation by sodium valproate and lithium","volume":"43","author":"De Sarno","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib34","doi-asserted-by":"crossref","DOI":"10.1042\/bj2960015","article-title":"Inactivation of glycogen synthase kinase-3\u03b2 by phosphorylation: new kinase connections in insulin and growth-factor signalling","volume":"296","author":"Sutherland","year":"1993","journal-title":"Biochem. J."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib35","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/j.1460-2075.1993.tb05715.x","article-title":"Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation","volume":"12","author":"Hughes","year":"1993","journal-title":"EMBO J."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00395-009-0054-y","article-title":"Proteasome inhibitor bortezomib promotes a rupture-prone plaque phenotype in ApoE-deficient mice","volume":"105","author":"Herck","year":"2010","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib37","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/CIRCRESAHA.110.224766","article-title":"The role of endoplasmic reticulum stress in the progression of atherosclerosis","volume":"107","author":"Tabas","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib38","doi-asserted-by":"crossref","first-page":"19739","DOI":"10.1074\/jbc.M710098200","article-title":"Akt regulates the survival of vascular smooth muscle cells via inhibition of FoxO3a and GSK3","volume":"283","author":"Allard","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib39","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1161\/ATVBAHA.109.196394","article-title":"Absence of Akt1 reduces vascular smooth muscle cell migration and survival and induces features of plaque vulnerability and cardiac dysfunction during atherosclerosis","volume":"29","author":"Fern\u00e1ndez-Hernando","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib40","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1128\/MCB.00279-09","article-title":"Mcl-1 integrates the opposing actions of signaling pathways that mediate survival and apoptosis","volume":"29","author":"Morel","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib41","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.molcel.2006.02.009","article-title":"Glycogen synthase Kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1","volume":"21","author":"Maurer","year":"2006","journal-title":"Mol. Cell."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib42","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nature06803","article-title":"Imaging of atherosclerotic cardiovascular disease","volume":"451","author":"Sanz","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib43","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/ncpcardio1086","article-title":"Rapid regression of atherosclerosis: insights from the clinical and experimental literature","volume":"5","author":"Williams","year":"2008","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib44","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1055\/s-0031-1295520","article-title":"Atherosclerosis: current status of prevention and treatment","volume":"20","author":"Whayne","year":"2011","journal-title":"Int. J. Angiol."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib45","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.2538","article-title":"Atherosclerosis: current pathogenesis and therapeutic options","volume":"17","author":"Weber","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2017.09.034_bib46","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/pds.2073","article-title":"Valproate attenuates the risk of myocardial infarction in patients with epilepsy: a nationwide cohort study","volume":"20","author":"Olesen","year":"2011","journal-title":"Pharmacoepidemiol. Drug Saf."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017313205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017313205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T23:58:33Z","timestamp":1570147113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915017313205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":46,"alternative-id":["S0021915017313205"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.09.034","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"4-phenylbutyrate and valproate treatment attenuates the progression of atherosclerosis and stabilizes existing plaques","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.09.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}